X4 Pharmaceuticals Quote - XFOR

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

0.75

Bid

0.75

Offer

0.81

Volume

1,367,261

0.73 Day's Range 0.8147

0.2612 52 Week Range 1.60

Market Cap

127.91M

Previous Close

0.7336

Open

0.7349

Last Trade

800

0.75

(formt)

Last Trade Time

Financial Volume

US$ 1,072,898

VWAP

0.784706

Average Volume (3m)

3,571,771

Shares Outstanding

170,546,469

Dividend Yield

PE Ratio

-1.28

Earnings Per Share (EPS)

-0.59

Revenue

Net Profit

-101.17M

X4 Pharmaceuticals Inc is clinical-stage biopharmaceutical company. It is focused on restoring the immune system function by developing therapeutics for the treatment of rare diseases. Its molecule therapeutics are antagonists of chemokine receptor CXCR4, which have the potential to treat a broad ra... X4 Pharmaceuticals Inc is clinical-stage biopharmaceutical company. It is focused on restoring the immune system function by developing therapeutics for the treatment of rare diseases. Its molecule therapeutics are antagonists of chemokine receptor CXCR4, which have the potential to treat a broad range of rare diseases, including primary immunodeficiencies (PIs) and cancer. Its product candidate, X4P-001, has completed a Phase 2 trial in patients with a rare genetic PI called Warts. The company is also developing X4P-002, a CXCR4 antagonist that has properties that could enable penetration of the blood-brain barrier and provide appropriate therapeutic exposures to treat brain cancers, including glioblastoma multiforme. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.x4pharma.com

Headquarters

Wilmington, Delaware, USA

Founded

X4 Pharmaceuticals Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker XFOR. The last closing price for X4 Pharmaceuticals was US$0.73. Over the last year, X4 Pharmaceuticals shares have traded in a share price range of US$ 0.2612 to US$ 1.60.

X4 Pharmaceuticals currently has 170,546,469 shares in issue. The market capitalisation of X4 Pharmaceuticals is US$125.11 million. X4 Pharmaceuticals has a price to earnings ratio (PE ratio) of -1.28.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.1485	24.6882793017	0.6015	0.8943	0.5979	3615937	0.79744204	CS
4	0.3608	92.7029804728	0.3892	0.8943	0.3716	4024309	0.67646608	CS
12	0.2219	42.0185570915	0.5281	0.8943	0.2612	3571771	0.50862005	CS
26	0.1612	27.3777173913	0.5888	0.8986	0.2612	2316831	0.55974437	CS
52	-0.1008	-11.8476727786	0.8508	1.6	0.2612	2436888	0.81679464	CS
156	-1.635	-68.5534591195	2.385	2.63	0.2612	1798942	1.11901881	CS
260	-10.07	-93.0683918669	10.82	11.16	0.2612	1151278	1.41547597	CS

XFOR - Frequently Asked Questions (FAQ)

What is the current X4 Pharmaceuticals share price?

The current share price of X4 Pharmaceuticals is US$ 0.75

How many X4 Pharmaceuticals shares are in issue?

X4 Pharmaceuticals has 170,546,469 shares in issue

What is the market cap of X4 Pharmaceuticals?

The market capitalisation of X4 Pharmaceuticals is USD 125.11M

What is the 1 year trading range for X4 Pharmaceuticals share price?

X4 Pharmaceuticals has traded in the range of US$ 0.2612 to US$ 1.60 during the past year

What is the PE ratio of X4 Pharmaceuticals?

The price to earnings ratio of X4 Pharmaceuticals is -1.28

What is the reporting currency for X4 Pharmaceuticals?

X4 Pharmaceuticals reports financial results in USD

What is the latest annual profit for X4 Pharmaceuticals?

The latest annual profit of X4 Pharmaceuticals is USD -101.17M

What is the registered address of X4 Pharmaceuticals?

The registered address for X4 Pharmaceuticals is 3411 SILVERSIDE ROAD TATNALL, BUILDING #104, WILMINGTON, DELAWARE, 19810

What is the X4 Pharmaceuticals website address?

The website address for X4 Pharmaceuticals is www.x4pharma.com

Which industry sector does X4 Pharmaceuticals operate in?

X4 Pharmaceuticals operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
ONCBeiGene Ltd	184.21 (731.65%)	129.32k
RAINRain Enhancement Technologies Holdco Inc	6.75 (457.85%)	212.43k
NITON2OFF Inc	US$ 1.07 (331.45%)	603.55M
CTCXCarmell Corporation	US$ 0.6991 (150.48%)	309.04M
TXMDTherapeuticsMD Inc	US$ 1.58 (83.72%)	7.4M
NMRANeumora Therapeutics Inc	US$ 1.965 (-81.46%)	44.29M
THCHTH International Limited	US$ 0.71 (-80.00%)	46.39k
MARXMars Acquisition Corporation	US$ 2.47 (-73.58%)	1.19M
SISIShineco Inc	US$ 2.07 (-54.30%)	1.73M
MARXUMars Acquisition Corporation	US$ 6.23 (-40.10%)	66.1k
NITON2OFF Inc	US$ 1.07 (331.45%)	603.87M
CTCXCarmell Corporation	US$ 0.6991 (150.48%)	314.15M
MBIOMustang Bio Inc	US$ 0.2093 (18.25%)	310.9M
CGBSCrown LNG Holdings Ltd	US$ 0.6749 (68.68%)	279.72M
SVMHSRIVARU Holding Ltd	US$ 0.0599 (42.28%)	278.85M